209528-69-8,MFCD12827787
Catalog No.:AA002K79

209528-69-8 | Methyl 3-(benzyloxy)-4-nitrobenzoate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
>95%
1 week  
$299.00   $209.00
- +
5mg
>95%
1 week  
$319.00   $223.00
- +
10mg
>95%
1 week  
$358.00   $250.00
- +
500mg
>95%
1 week  
$403.00   $282.00
- +
1g
>95%
1 week  
$514.00   $360.00
- +
5g
>95%
1 week  
$1,112.00   $779.00
- +
10g
>95%
1 week  
$1,710.00   $1,197.00
- +
25g
>95%
1 week  
$3,505.00   $2,454.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA002K79
Chemical Name:
Methyl 3-(benzyloxy)-4-nitrobenzoate
CAS Number:
209528-69-8
Molecular Formula:
C15H13NO5
Molecular Weight:
287.2674
MDL Number:
MFCD12827787
SMILES:
COC(=O)c1ccc(c(c1)OCc1ccccc1)[N+](=O)[O-]
Properties
Computed Properties
 
Complexity:
362  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
5  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.1  

Downstream Synthesis Route

[1]Locationinpatent:bodytextBörger,Carsten;Knölker,Hans-Joachim[Synlett,2008,#11,p.1698-1702]

[2]Locationinpatent:experimentalpartBörger,Carsten;Knölker,Hans-Joachim[Tetrahedron,2012,vol.68,#33,p.6727-6736]

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2006/103088,2006,A1Locationinpatent:Page/Pagecolumn23

[4]CurrentPatentAssignee:SZEGEDBIOLOGICALRESEARCHCENTER;UNIVERSITYOFLJUBLJANA-WO2020/48949,2020,A1Locationinpatent:Page/Pagecolumn62

[5]Murphy,NatashaS.;Prabhakaran,Panchami;Azzarito,Valeria;Plante,JeffreyP.;Hardie,MichaeleJ.;Kilner,ColinA.;Warriner,StuartL.;Wilson,AndrewJ.[Chemistry-AEuropeanJournal,2013,vol.19,#18,p.5546-5550]

[6]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synlett,2005,#20,p.3071-3074]

[7]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synthesis,2006,#20,p.3467-3477]

[8]Bavinton,ClementineE.;Hamilton,AndrewD.;Knipe,PeterC.;Luo,Jinghui;Sternke-Hoffmann,Rebecca;Thompson,Sam;Yamashita,Tohru[ChemicalCommunications,2022,vol.58,#33,p.5132-5135]

[1]Locationinpatent:bodytextBörger,Carsten;Knölker,Hans-Joachim[Synlett,2008,#11,p.1698-1702]

[2]Locationinpatent:experimentalpartBörger,Carsten;Knölker,Hans-Joachim[Tetrahedron,2012,vol.68,#33,p.6727-6736]

[3]CurrentPatentAssignee:PROTEGOBIOPHARMA-WO2021/154842,2021,A1Locationinpatent:Paragraph0871-0874

[4]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synlett,2005,#20,p.3071-3074]

[5]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2006/103088,2006,A1Locationinpatent:Page/Pagecolumn23

[6]CurrentPatentAssignee:SZEGEDBIOLOGICALRESEARCHCENTER;UNIVERSITYOFLJUBLJANA-WO2020/48949,2020,A1Locationinpatent:Page/Pagecolumn62

[7]Durcik,Martina;Tammela,Päivi;Barančoková,Michaela;Tomašič,Tihomir;Ilaš,Janez;Kikelj,Danijel;Zidar,Nace[ChemMedChem,2018,vol.13,#2,p.186-198]

[8]CurrentPatentAssignee:UNIVERSITYOFLJUBLJANA-WO2022/129327,2022,A1Locationinpatent:Page/Pagecolumn92

[9]CurrentPatentAssignee:UNIVERSITYOFLJUBLJANA-WO2022/129327,2022,A1Locationinpatent:Page/Pagecolumn92

[10]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synthesis,2006,#20,p.3467-3477]

[11]CurrentPatentAssignee:PFIZERINC-US2003/96826,2003,A1

[12]Prabhakaran,Panchami;Azzarito,Valeria;Jacobs,Tia;Hardie,MichaeleJ.;Kilner,ColinA.;Edwards,ThomasA.;Warriner,StuartL.;Wilson,AndrewJ.[Tetrahedron,2012,vol.68,#23,p.4485-4491]

[13]Azzarito,Valeria;Prabhakaran,Panchami;Bartlett,AliceI.;Murphy,NatashaS.;Hardie,MichaeleJ.;Kilner,ColinA.;Edwards,ThomasA.;Warriner,StuartL.;Wilson,AndrewJ.[OrganicandBiomolecularChemistry,2012,vol.10,#32,p.6469-6472]

[14]Chen,Lijia;Yap,JeremyL.;Yoshioka,Makoto;Lanning,MaryannaE.;Fountain,RachelN.;Raje,Mithun;Scheenstra,JacobA.;Strovel,JeffreyW.;Fletcher,Steven[ACSMedicinalChemistryLetters,2015,vol.6,#7,p.764-769]

[15]Raj,GaneshV.;Sareddy,GangadharaReddy;Ma,Shihong;Lee,Tae-Kyung;Viswanadhapalli,Suryavathi;Li,Rui;Liu,Xihui;Murakami,Shino;Chen,Chien-Cheng;Lee,Wan-Ru;Mann,Monica;Krishnan,SamayaRajeshwari;Manandhar,Bikash;Gonugunta,VijayK.;Strand,Douglas;Tekmal,RajeshwarRao;Ahn,Jung-Mo;Vadlamudi,RatnaK.[eLife,2017,vol.6]

[1]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synthesis,2006,#20,p.3467-3477]

[2]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synlett,2005,#20,p.3071-3074]

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2006/103088,2006,A1

[1]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synthesis,2006,#20,p.3467-3477]

[2]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synlett,2005,#20,p.3071-3074]

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2006/103088,2006,A1

[1]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synthesis,2006,#20,p.3467-3477]

[2]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synlett,2005,#20,p.3071-3074]

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2006/103088,2006,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:209528-69-8 Molecular Formula|209528-69-8 MDL|209528-69-8 SMILES|209528-69-8 Methyl 3-(benzyloxy)-4-nitrobenzoate
Catalog No.: AA002K79
209528-69-8,MFCD12827787
209528-69-8 | Methyl 3-(benzyloxy)-4-nitrobenzoate
Pack Size: 1mg
Purity: >95%
1 week
$299.00 $209.00
Pack Size: 5mg
Purity: >95%
1 week
$319.00 $223.00
Pack Size: 10mg
Purity: >95%
1 week
$358.00 $250.00
Pack Size: 500mg
Purity: >95%
1 week
$403.00 $282.00
Pack Size: 1g
Purity: >95%
1 week
$514.00 $360.00
Pack Size: 5g
Purity: >95%
1 week
$1,112.00 $779.00
Pack Size: 10g
Purity: >95%
1 week
$1,710.00 $1,197.00
Pack Size: 25g
Purity: >95%
1 week
$3,505.00 $2,454.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA002K79
Chemical Name: Methyl 3-(benzyloxy)-4-nitrobenzoate
CAS Number: 209528-69-8
Molecular Formula: C15H13NO5
Molecular Weight: 287.2674
MDL Number: MFCD12827787
SMILES: COC(=O)c1ccc(c(c1)OCc1ccccc1)[N+](=O)[O-]
Properties
Complexity: 362  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 21  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 5  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.1  
Downstream Synthesis Route
209528-69-8    475215-88-4 

[1]Locationinpatent:bodytextBörger,Carsten;Knölker,Hans-Joachim[Synlett,2008,#11,p.1698-1702]

[2]Locationinpatent:experimentalpartBörger,Carsten;Knölker,Hans-Joachim[Tetrahedron,2012,vol.68,#33,p.6727-6736]

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2006/103088,2006,A1Locationinpatent:Page/Pagecolumn23

[4]CurrentPatentAssignee:SZEGEDBIOLOGICALRESEARCHCENTER;UNIVERSITYOFLJUBLJANA-WO2020/48949,2020,A1Locationinpatent:Page/Pagecolumn62

[5]Murphy,NatashaS.;Prabhakaran,Panchami;Azzarito,Valeria;Plante,JeffreyP.;Hardie,MichaeleJ.;Kilner,ColinA.;Warriner,StuartL.;Wilson,AndrewJ.[Chemistry-AEuropeanJournal,2013,vol.19,#18,p.5546-5550]

[6]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synlett,2005,#20,p.3071-3074]

[7]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synthesis,2006,#20,p.3467-3477]

[8]Bavinton,ClementineE.;Hamilton,AndrewD.;Knipe,PeterC.;Luo,Jinghui;Sternke-Hoffmann,Rebecca;Thompson,Sam;Yamashita,Tohru[ChemicalCommunications,2022,vol.58,#33,p.5132-5135]

713-52-0    100-39-0    209528-69-8 

[1]Locationinpatent:bodytextBörger,Carsten;Knölker,Hans-Joachim[Synlett,2008,#11,p.1698-1702]

[2]Locationinpatent:experimentalpartBörger,Carsten;Knölker,Hans-Joachim[Tetrahedron,2012,vol.68,#33,p.6727-6736]

[3]CurrentPatentAssignee:PROTEGOBIOPHARMA-WO2021/154842,2021,A1Locationinpatent:Paragraph0871-0874

[4]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synlett,2005,#20,p.3071-3074]

[5]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2006/103088,2006,A1Locationinpatent:Page/Pagecolumn23

[6]CurrentPatentAssignee:SZEGEDBIOLOGICALRESEARCHCENTER;UNIVERSITYOFLJUBLJANA-WO2020/48949,2020,A1Locationinpatent:Page/Pagecolumn62

[7]Durcik,Martina;Tammela,Päivi;Barančoková,Michaela;Tomašič,Tihomir;Ilaš,Janez;Kikelj,Danijel;Zidar,Nace[ChemMedChem,2018,vol.13,#2,p.186-198]

[8]CurrentPatentAssignee:UNIVERSITYOFLJUBLJANA-WO2022/129327,2022,A1Locationinpatent:Page/Pagecolumn92

[9]CurrentPatentAssignee:UNIVERSITYOFLJUBLJANA-WO2022/129327,2022,A1Locationinpatent:Page/Pagecolumn92

[10]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synthesis,2006,#20,p.3467-3477]

[11]CurrentPatentAssignee:PFIZERINC-US2003/96826,2003,A1

[12]Prabhakaran,Panchami;Azzarito,Valeria;Jacobs,Tia;Hardie,MichaeleJ.;Kilner,ColinA.;Edwards,ThomasA.;Warriner,StuartL.;Wilson,AndrewJ.[Tetrahedron,2012,vol.68,#23,p.4485-4491]

[13]Azzarito,Valeria;Prabhakaran,Panchami;Bartlett,AliceI.;Murphy,NatashaS.;Hardie,MichaeleJ.;Kilner,ColinA.;Edwards,ThomasA.;Warriner,StuartL.;Wilson,AndrewJ.[OrganicandBiomolecularChemistry,2012,vol.10,#32,p.6469-6472]

[14]Chen,Lijia;Yap,JeremyL.;Yoshioka,Makoto;Lanning,MaryannaE.;Fountain,RachelN.;Raje,Mithun;Scheenstra,JacobA.;Strovel,JeffreyW.;Fletcher,Steven[ACSMedicinalChemistryLetters,2015,vol.6,#7,p.764-769]

[15]Raj,GaneshV.;Sareddy,GangadharaReddy;Ma,Shihong;Lee,Tae-Kyung;Viswanadhapalli,Suryavathi;Li,Rui;Liu,Xihui;Murakami,Shino;Chen,Chien-Cheng;Lee,Wan-Ru;Mann,Monica;Krishnan,SamayaRajeshwari;Manandhar,Bikash;Gonugunta,VijayK.;Strand,Douglas;Tekmal,RajeshwarRao;Ahn,Jung-Mo;Vadlamudi,RatnaK.[eLife,2017,vol.6]

209528-69-8    881909-64-4 

[1]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synthesis,2006,#20,p.3467-3477]

[2]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synlett,2005,#20,p.3071-3074]

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2006/103088,2006,A1

209528-69-8    881909-58-6 

[1]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synthesis,2006,#20,p.3467-3477]

[2]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synlett,2005,#20,p.3071-3074]

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2006/103088,2006,A1

209528-69-8    881909-62-2 

[1]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synthesis,2006,#20,p.3467-3477]

[2]Charrier,Nicolas;Demont,Emmanuel;Dunsdon,Rachel;Maile,Graham;Naylor,Alan;O'Brien,Alistair;Redshaw,Sally;Theobald,Pam;Vesey,David;Walter,Daryl[Synlett,2005,#20,p.3071-3074]

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2006/103088,2006,A1

Building Blocks More >
2101-86-2
2101-86-2
Benzene, 1-azido-4-methyl-
AA002KI2 | MFCD09971470
2105-94-4
2105-94-4
4-Bromo-2-fluorophenol
AA002KRM | MFCD00011722
210962-09-7
210962-09-7
1-(Pyridin-4-yl)piperidine-4-carboxylic acid hydrochloride
AA002L05 | MFCD04039919
22888-51-3
22888-51-3
Dl-2'-methylphenylalanine hydrochloride
AA002LAF | MFCD01823323
229613-93-8
229613-93-8
(3Ar,4r,6s,6as)-methyl 4-(tert-butoxycarbonylamino)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3ah-cyclopenta[d]isoxazole-6-carboxylate
AA002LLU | MFCD18206350
230301-11-8
230301-11-8
t-Butyl 1H,4H,6H,7H-pyrazolo[4,3-c]pyridine-5-carboxylate
AA002LUQ | MFCD08059268
23088-23-5
23088-23-5
Methyl 6-quinoxalinecarboxylate
AA002M32 | MFCD00102618
23169-37-1
23169-37-1
2-Amino-9-(4-hydroxybutyl)-1H-purin-6(9H)-one
AA002MD3
23267-68-7
23267-68-7
1-Propanesulfinyl chloride
AA002MNB | MFCD28118495
2339-78-8
2339-78-8
1,2-Dichloro-4-fluoro-5-nitrobenzene
AA002MZY | MFCD00075330
Submit
© 2017 AA BLOCKS, INC. All rights reserved.